Medtronic set to launch CRT-pacemaker

Candace Stuart | | Cardiovascular Business | Heart Failure

The FDA approved a cardiac resynchronization therapy-pacemaker (CRT-P) for patients with heart failure or atrioventricular block.

Medtronic announced that it received the OK to launch its Viva CRT-P device in the U.S. The company won approval in Europe for the same technology in May.

Viva CRT-P uses a proprietary algorithm, AdaptivCRT, which in studies has shown clinical and economic benefits. In heart failure patients, it helped to improve response to the therapy, reduce the risk of atrial fibrillation and reduce 30-day hospital readmissions and related resource use. In addition, the device includes diagnostics tools for monitoring fluid status and assessing patients’ physiological condition.

 

Candace Stuart, Contributor

Related Content

Medtronic using AI to identify more TAVR patients in need
Tirzepatide linked to significant weight loss, ‘impressive’ diabetes prevention after 3 years
Most heart failure patients miss out on guideline-recommended palliative care
CMS updates outpatient reimbursement policy for Barostim device
American Heart Association announces late-breaking research for Scientific Sessions 2024
Impella ECP confirmed to be safe for high-risk PCI—is FDA approval next?

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."